| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| Cost of Revenue | $0 | -100.0% |
| Gross Profit | $0 | +100.0% |
| R&D Expense | $25K | +0.0% |
| SG&A Expense | $709K | +82.9% |
| Operating Income | -$739K | -63.3% |
| Pre-tax Income | -$1.1M | +32.8% |
| Income Tax | $0 | -100.0% |
| Net Income | -$1.1M | +32.9% |
| EPS (Basic) | -$0.09 | +35.7% |
| EPS (Diluted) | -$0.09 | +35.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $0 | -100.0% |
| Inventory | $60K | +12.5% |
| Current Assets | $1.4M | -0.7% |
| Total Assets | $2.0M | -8.4% |
| Current Liabilities | $8.8M | +25.6% |
| Stockholders' Equity | -$6.8M | -39.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $188K | +340.5% |
| Investing Cash Flow | $142K | +1740.9% |
| Financing Cash Flow | -$330K | -516.5% |